Likewise, CSF markers of endothelial injury, including ICAM‐1 and VCAM‐1, were elevated in preclinical AD in relation to CSF tau, cortical thinning, and cognitive decline.14 The gene discussed is MAPT; the disease is Alzheimer disease.